[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340296-105":59,"doc-detail-340296-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","foxa1-induced-by-rc48-regulates-her2-transcription-to-enhance-the-tumorigenic-capacity-of-lung-cancer-through-pi3kakt-pathway","FOXA1, induced by RC48, regulates HER2 transcription to enhance the tumorigenic capacity of lung cancer through PI3K/AKT pathway","","Lung cancer has the highest global incidence and mortality, yet a subset of patients gains little benefit from targeted therapy, immunotherapy, and chemotherapy. Disitamab vedotin (RC48), a HER2-targeting antibody drug approved mainly for gastric and bladder cancers, shows limited prior study in lung cancer. This study finds FOXA1 directly binds the HER2 promoter, modulating HER2/PI3K/AKT signaling to regulate proliferation and apoptosis. RC48 also impacts the FOXA1/HER2/PI3K/AKT axis, suppressing tumorigenic behavior, and high FOXA1/HER2 levels associate with progression and poor prognosis, suggesting biomarkers and therapeutic targets.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/foxa1-induced-by-rc48-regulates-her2-transcription-to-enhance-the-tumorigenic-capacity-of-lung-cancer-through-pi3kakt-pathway/340296/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/foxa1-induced-by-rc48-regulates-her2-transcription-to-enhance-the-tumorigenic-capacity-of-lung-cancer-through-pi3kakt-pathway/340296.png","ImageObject",300,407,{"name":92,"@type":93},"Skyler","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-10","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What role does FOXA1 play in HER2 regulation in lung cancer?","Question",{"text":113,"@type":114},"FOXA1 directly binds the promoter region of HER2, affecting HER2/PI3K/AKT signaling and consequently influencing proliferation and apoptosis-related factors in lung cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does RC48 affect signaling pathways in lung cancer cells?",{"text":118,"@type":114},"RC48 influences the HER2/PI3K/AKT pathway and also affects the FOXA1/HER2/PI3K/AKT pathway, producing a strong antitumor effect.",{"name":120,"@type":111,"acceptedAnswer":121},"Do FOXA1 and HER2 expression levels relate to clinical outcomes?",{"text":122,"@type":114},"Yes. Higher expressions of FOXA1 and HER2 correlate positively with clinical progression and poorer prognosis.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},340296,1790176748,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Ivyspring  \nInternational Publisher  \nJournal of Cancer  \n2024; 15(18): 5863-5875. doi: 10.7150/jca.100210  \nResearch Paper  \nFOXA1, induced by RC48, regulates HER2 transcription to enhance the tumorigenic capacity of lung cancer through PI3K/AKT pathway  \nMengyang Zhao1, Ning Zhang2, Yijun Wang1, Kang Han4, Tianhui Gao1􀀍, Xue Li3􀀍  \n1. Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.  \n2. Department of Radiology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.  \n3. Ophthalmology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.  \n4. Department of Pathology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.  \n􀀍 Corresponding authors: Xue Li and Tianhui Gao, Department of Oncology, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China. E-mail: [lixue890520@163.com](lixue890520@163.com); [TianhuiGao@163.com](TianhuiGao@163.com).  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [http://ivyspring.com/terms](http://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2024.06.27; Accepted: 2024.08.25; Published: 2024.09.16  \nAbstract  \nLung cancer remains the tumor with the highest global incidence and mortality rates. Current primary treatment modalities encompass targeted therapy, immunotherapy, and chemotherapy; however, a subset of patients derives no benefit from these interventions. Recently, the HER2-targeting antibody drug Disitamab vedotin (RC48) was approved and introduced primarily for gastric and bladder cancers, with minimal investigation in the field of lung cancer. This study demonstrates that FOXA1 directly binds to the promoter region of HER2, influencing the HER2/PI3K/AKT signaling pathway, which consequently modulates factors that foster lung cancer proliferation and impede apoptosis. Unlike FOXA1, HER2 does not influence the expression of FOXA1. Intriguingly, in lung cancer cells, RC48 not only impacts the HER2/PI3K/AKT pathway but also affects the FOXA1/HER2/PI3K/AKT pathway, thereby exerting a robust antitumor effect. In clinical specimens, heightened expressions of FOXA1 and HER2 correlate positively with clinical progression and poorer prognosis. These findings suggest that FOXA1 may serve as a potential biomarker or therapeutic target in future non-small cell lung cancer (NSCLC) treatments, and ongoing research may position RC48 as a transformative agent in lung cancer therapy.  \nKeywords: FOXA1; RC48; HER2; proliferation; apoptosis.  \nIntroduction  \nLung cancer is the malignancy with the highest global incidence, mortality, and growth rate, posing a significant threat to human health and life[1,2] . At initial diagnosis, approximately one-third of NSCLC patients cannot receive radical surgical treatment due to metastasis. The primary methods of treatment include chemotherapy, targeted therapy, and immunotherapy. HER2, belonging to the epidermal growth factor receptor (EGFR) family, has no identified ligands for direct interaction. It primarily activates the MEK-ERK-MAPK pathway and the PI3K-AKT bypass by forming heterodimers with other family members for signal transmission. HER2 variations encompass gene mutations, gene  \namplification, and protein overexpression. Unlike the prevalent gene amplification and protein overexpression in breast and gastric cancers, NSCLC primarily exhibits HER2 variations through gene mutations [3,4] . The mutation rate of HER2 in NSCLC ranges between 1% and 4%, predominantly occurring in non-smokers, females, and lung adenocarcinoma patients[5,6], with over 90% presenti","cbCaivdvjPunSmqa","https://ap.wps.com/l/cbCaivdvjPunSmqa","pdf",4841345,"English","# Abstract\n# Introduction\n## HER2 biology and clinical treatment context\n## ADCs and HER2-targeted therapeutic strategies","[{\"question\":\"What role does FOXA1 play in HER2 regulation in lung cancer?\",\"answer\":\"FOXA1 directly binds the promoter region of HER2, affecting HER2/PI3K/AKT signaling and consequently influencing proliferation and apoptosis-related factors in lung cancer.\"},{\"question\":\"How does RC48 affect signaling pathways in lung cancer cells?\",\"answer\":\"RC48 influences the HER2/PI3K/AKT pathway and also affects the FOXA1/HER2/PI3K/AKT pathway, producing a strong antitumor effect.\"},{\"question\":\"Do FOXA1 and HER2 expression levels relate to clinical outcomes?\",\"answer\":\"Yes. Higher expressions of FOXA1 and HER2 correlate positively with clinical progression and poorer prognosis.\"}]","FOXA1, induced by RC48, regulates HER2 transcription to enhance the tumorigenic capacity of lung cancer through PI3K/AKT pathway | PDF",1790035580,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8550abb144a70dd08f79809f5fb3c793.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d55497ebfb0ae5acae4d713397b4299.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/210fe6de6dc2df5511069548cc3e8990.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1cb3937ac9f45936b2d30bd315844a9.webp",980,1268]